# Stratus Medical

> Stratus Medical is a private medical device company that sells radiofrequency ablation tools to pain specialists, hospitals and ambulatory surgery centres. Its flagship Nimbus electrode deploys multiple tines to create a large treatment lesion; its portfolio also includes Vesta cannulas, reusable and disposable probes, and physician education. It sells directly in the United States and through overseas distributors.

- **Founded:** 2019
- **Headquarters:** Magnolia, United States
- **Founders:** Bret Boudousquie (Co-founder and CEO), Travis Sessions (Co-founder; Med Venture Holdings managing partner at launch)
- **Products:** Nimbus RF Multitined Expandable Electrode, Vesta RF Cannula, Nimbus Reusable Probe, Nimbus Disposable Probe, Physician education and clinical support
- **Notable:** Acquired NimbusRF assets from Biomerics in January 2020., Ranked 483 in the 2024 Deloitte Technology Fast 500, reporting 212% revenue growth over the evaluated three-year period., Named to Fortune’s America’s Most Innovative Companies list for 2026.

## Products & services

- **Nimbus RF Multitined Expandable Electrode** — Expandable multitined electrode used with an RF generator and probe to create large-volume heat lesions for pain treatment. The technology predates Stratus; the company reports initial FDA clearance in 2012.
- **Vesta RF Cannula** — Standard RF cannula for pain-treatment scenarios where the large-lesion Nimbus device is not indicated; US clearance and first treatments announced July 2020.
- **Nimbus Reusable Probe** — Reusable RF electrode offered in multiple lengths; compatible generators and adapter cables are specified in the product catalogue.
- **Nimbus Disposable Probe** — Single-use RF electrode available in multiple lengths.
- **Physician education and clinical support** — Cadaveric courses, webinars, staff in-service, case support and a physician-authored procedural textbook.
- **Stratus Medical RF Generator** — Development-stage RF generator; the current company page says it has not been evaluated by the FDA and is not FDA cleared.
- **neurovasis BVNA system** — Development-stage basivertebral nerve ablation technology building on the multitined design; not FDA cleared according to the current company page.

## Achievements

- Acquired NimbusRF assets from Biomerics in January 2020.
- Ranked 483 in the 2024 Deloitte Technology Fast 500, reporting 212% revenue growth over the evaluated three-year period.
- Named to Fortune’s America’s Most Innovative Companies list for 2026.
- Current website reports 42 US and overseas patents and more than 500,000 Nimbus treatments.
- Company reports ISO 13485:2016 certification.

## Latest updates

- **2026-02** — Announced $10 million Series B to complete generator and neurovasis development, support intellectual property and fund a clinical study.
- **2026-03** — Announced inclusion on Fortune’s America’s Most Innovative Companies list.
- **2026-04** — Osteotec announced exclusive UK distribution agreement.
- **2026-06** — COBRA trial results first posted June 26; record identifies termination due to slow enrollment following insurance changes.
- **2026-09** — UAMS Nimbus-versus-Stryker Venom trial record updated September 10; listed as recruiting, with estimated completion in September 2027.

## Links

- Website: https://stratusmedical.com
- LinkedIn: https://www.linkedin.com/company/stratusmedical
- Twitter/X: https://twitter.com/stratusmed
- Instagram: https://www.instagram.com/stratus.med/
- Facebook: https://www.facebook.com/stratusmedicalllc

---

Profile page: https://yespress.io/stratus-medical
Published by YesPress — https://yespress.io
Last updated: 2026-10-04